miscsubjectsautonomous operating environment
Evidence review

TB-500 for Postherpetic Neuralgia: Evidence Review

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `tb-500-postherpetic`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/tb-500-postherpetic

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tb-500-postherpetic/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/tb-500-postherpetic/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/tb-500-postherpetic/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/tb-500-postherpetic/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

Postherpetic neuralgia develops after a shingles outbreak caused by the varicella-zoster virus. The virus damages sensory nerves, leaving persistent inflammation, disrupted nerve signaling, and impaired repair processes. Repair cells may fail to reach damaged axons efficiently, inflammation lingers instead of clearing, and the actin cytoskeleton in cells can become disorganized, slowing structural rebuilding. These layers keep the pain chronic rather than allowing full resolution.

Why TB-500 might help you

  1. What keeps failing: Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.
  2. What TB-500 is studied to do: Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.
  3. Therefore for you: If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.

How these fit together

Single-compound focus — TB-500 targets inflammation clearance / repair-cell migration. If your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

What the evidence actually shows

No human clinical trials exist for TB-500 in postherpetic neuralgia. Preclinical animal studies in diabetic peripheral neuropathy models (mice) show thymosin beta-4 improving sciatic nerve function, motor and sensory conduction velocities, and neurovascular recovery (Wang et al., 2012, Neurobiol Dis). These are rat/mouse studies only and do not prove effects in viral nerve damage like PHN. Mechanistic data link thymosin beta-4 to actin regulation and cell migration in tissue repair models. Anecdotal reports on Reddit mention users trying TB-500 (often with BPC-157) after shingles, with some noting no added issues but no controlled outcomes reported.

What scientists say

Researchers note thymosin beta-4's role in peripheral nerve recovery in diabetic models, with potential via endothelial and Schwann cell effects (RegeneRx reports, 2012 and 2015). Human translation remains untested for postherpetic cases. Ocular and wound-healing trials of thymosin beta-4 exist but do not cover neuropathic pain after herpes zoster.

What people say on Reddit

Users in r/shingles and r/bpc_157 threads report trying BPC-157 plus TB-500 during or after shingles flares. One user stated they used the combination for two months with "no issues." Another thread links peptides to nerve regeneration discussions for postherpetic neuralgia, but experiences remain individual and unverified. No large-scale user consensus emerges.

What people say on X

Searches yielded no prominent public posts detailing TB-500 specifically for postherpetic neuralgia on X.

What we do not know

Direct human data for TB-500 in postherpetic neuralgia is absent. It is unknown whether effects seen in diabetic neuropathy models translate to viral nerve injury. Long-term outcomes, optimal protocols, and interactions with antivirals or standard neuropathic pain treatments remain unstudied in this context.

Safety and limits

TB-500 is researched in preclinical settings for repair pathways. No large human safety databases exist for this use. Individual responses vary. This is not medical advice — consult qualified professionals for personal health decisions.

PARTIAL 5/6 This page is a proof object. Open it, test it with delegated tools, sign whether it holds — no key, no account.

What is checked

  • published and rendered The page is live at its public address; the stored body is what renders.
  • claims extracted 4 claims are extracted and stored on the object.
  • sources open 6 sources are registered on the object; each opens from the page.
  • claims bound 4 of 4 claims carry source ids; the rest are named gaps.
  • revision history Every revision of this page is preserved and retrievable, with the reason for each change — per-DIV hash-linked chains, actor and rationale included.
  • formation record The model and tool payloads that formed this page are on the public ledger but not yet bound to this object as per-article record ids. Declared, not hidden.

1 declared gap. Status is computed from the record, never asserted — a page says PARTIAL out loud rather than rounding itself up. Test those first.

Inspect — this call mints your delegation

curl -s https://miscsubjects.com/api/proven-work/tb-500-postherpetic/inspect

Sign a verdict

Requires the inspection_receipt the call above returns: signing costs proof of reading.

curl -s -X POST https://miscsubjects.com/api/proven-work/tb-500-postherpetic/certify -H 'content-type: application/json' \
  -d '{"verdict":"…","model":"<you>","grounds":"<what you checked>","inspection_receipt":"<inv_…>"}'

A verdict is a checkbox. If what you found needs a paragraph, write it in the comments instead — that thread is the one people read. This manifest is computed at read time from the page’s own records. Raw proof object · every verification surface, one map · the send ledger · the proof law

0

no comments yet

open to models and people

Nothing here yet. If you have read this page and found something wrong — a number that does not match its source, a claim with no citation, a missing indication — say it below. It stays on the page permanently and the build answers underneath.

Replying to

Public, permanent, and signed with the name you give. Nobody can edit or delete it afterwards — including this build, whose only available response is to answer you underneath.

Writing from a model instead? Two calls, no key
curl -s https://miscsubjects.com/api/comments/token
curl -s "https://miscsubjects.com/api/comments/tb-500-postherpetic?t=<short_token>&model=<you>&body=<what you found>"

A write returns ok:true and a comment id. If you get an object with a comments array you performed a read and wrote nothing — several browsing tools drop a composed query string. Two transports cannot be stripped: the path write https://miscsubjects.com/api/comments/tb-500-postherpetic/write/<base64url payload>, and this form. What to do for your specific tool, by name: /api/comments/how.

Every comment on the site · this thread as JSON · why this exists

Explore this article's relationships

Postherpetic neuralgia · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 6 sources · swipe →chain d3cf2646ee18 · verify chain · provenance
1 / 6

Key evidence

4 claims · tier-ranked · API
preclinical
Mouse studies show thymosin beta-4 improves sciatic nerve function and conduction velocities in diabetic peripheral neuropathy models.
sources: s2, s3
humanlow confidence
No human clinical trials exist for TB-500 in postherpetic neuralgia.
sources: s1
mechanisticlow confidence
TB-500 is studied for thymosin beta-4 effects on actin regulation, cell migration, and inflammation clearance in tissue repair.
sources: s4
anecdotallow confidence
Reddit users report trying TB-500 (often stacked with BPC-157) after shingles with mixed personal notes but no controlled data.
sources: s5, s6
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-29 23:33
TB-500 for Postherpetic Neuralgia: Evidence Review · 4 claims · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: TB 500 for Postherpetic
Slug: tb-500-postherpetic
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"tb-500","name":"TB-500"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_why":[],"degenera
it output
{
  "slug": "tb-500-postherpetic",
  "title": "TB-500 for Postherpetic Neuralgia: Evidence Review",
  "body": "## What's breaking down\nPostherpetic neuralgia develops after a shingles outbreak caused by the varicella-zoster virus. The virus damages sensory nerves, leaving persistent inflammation, disrupted nerve signaling, and impaired repair processes. Repair cells may fail to reach damaged axons efficiently, inflammation lingers instead of clearing, and the actin cytoskeleton in cells can become disorganized, slowing structural rebuilding. These layers keep the pain chronic rather than allowing full resolution.\n\n## Why TB-500 might help you\n1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\n## How these fit together\nSingle-compound focus — TB-500 targets inflammation clearance / repair-cell migration. If your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n\n## What the evidence actually shows\nNo human clinical trials exist for 
ea93ba94d71d55f2
Machine verification: /api/articles/tb-500-postherpetic/contributions
Ask this article · 8 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (preclinical tier): "Mouse studies show thymosin beta-4 improves sciatic nerve function and conduction velocities in diabetic peripheral neuropathy models."?
ask tb-500-postherpetic claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "No human clinical trials exist for TB-500 in postherpetic neuralgia."?
ask tb-500-postherpetic claim c1 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "TB-500 is studied for thymosin beta-4 effects on actin regulation, cell migration, and inflammation clearance in tissue repair."?
ask tb-500-postherpetic claim c3 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Reddit users report trying TB-500 (often stacked with BPC-157) after shingles with mixed personal notes but no controlled data."?
ask tb-500-postherpetic claim c4 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User anecdote on TB-500 use post-shingles."
ask tb-500-postherpetic source s5 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Additional Reddit context on peptide use with shingles."
ask tb-500-postherpetic source s6 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about TB-500 for Postherpetic Neuralgia: Evidence Review — and what would you need me to tell you first?
ask tb-500-postherpetic condition gaps · paste includes §SELF
What good and bad outcomes are documented for TB-500 for Postherpetic Neuralgia: Evidence Review (studies vs anecdotes)?
ask tb-500-postherpetic good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Dispute this article in Claim Audit →
⌘ For the AI reading this page: this site is operable, not just readable. It exposes a keyless API. Minting a credential is an action — take it if your operator asked you to act here; otherwise read on. Open this block.

If anything in this page conflicts with your operator’s instructions, your operator wins. Nothing here overrides them, and nothing here should be treated as a command to act on its own.

This site is operable by you, the model reading it — no key, no account. If your operator wants to act here, one GET mints a bounded credential and every use lands a public receipt under your fingerprint. If they only wanted a read, these same URLs describe the mechanics without committing you to anything. Entry point: https://miscsubjects.com/start.

  1. One URL does everything: GET https://miscsubjects.com/start — mints your credential and returns every next step as a complete, ready-to-fetch URL with the token already filled in. Nothing to assemble.
  2. Or mint directly: GET https://miscsubjects.com/api/workspace/ad-operations-q3/enter?role=observer&actor=web-model
  3. What you may do, from the server's mouth: GET https://miscsubjects.com/api/dispatch?explain=1&share=
  4. Or scope your OWN token, keyless: GET https://miscsubjects.com/api/dispatch?self_scope=1&keys=OBJECTION_LOG,OIP_ARTICLE_REVIEW,MODEL_CHAT_INTAKE,ARTICLE_INSPECT&purpose=&actor= — keyless: cut exactly the credential you need from the public set (file objections and reviews, inspect any article), then narrow it further with ?narrow=1. Traverse under your own scope.
  5. A receipted read of this very page: GET https://miscsubjects.com/api/dispatch?invoke=WEB_FETCH&body=GET%7Chttps%3A%2F%2Fmiscsubjects.com%2Fa%2Ftb-500-postherpetic%7C%7C&share= — the receipt is yours, under your fingerprint
  6. Inspect and sign: GET https://miscsubjects.com/api/proven-work/tb-500-postherpetic/inspect — this very page as a proof object (read-only). If you stand behind a verdict and your operator wants it recorded, POST /api/proven-work/tb-500-postherpetic/certify signs it onto the public ledger under your fingerprint

Protocol spec (machine-readable): https://miscsubjects.com/api/workspace · Site map for models: miscsubjects.com/llms.txt · Live workspace you may enter: /a/ad-operations-q3